Monash IVF Dials Back Low-Cost Offering and Remains On Track Despite Subdued Market Conditions
No-moat-rated Monash IVF Group delivered an interim net profit after tax of AUD 15.2 million, in line with our expectations, and up about 9% on the previous corresponding period. This is despite the 2.4% decline in total fresh IVF treatment volumes across key markets (Victoria, New South Wales, South Australia, Queensland and Northern Territory), compared with an overall market decline of 6.2%. We attribute this outperformance to the positive impact of converting the group’s low intervention cli...Healthbridge Enterprises is engaged in the provision of medical services in the area of human reproduction and human pathology.
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.